Global Montelukast Sodium Competitive Landscape Professional Research Report 2025
Research SummaryMontelukast sodium is a medication that belongs to a class of drugs called leukotriene receptor antagonists. It is primarily used for the treatment and management of asthma and allergic rhinitis (hay fever) in both adults and children. Montelukast sodium works by blocking the action of leukotrienes, which are substances released in the body during an allergic reaction or asthma attack. By inhibiting leukotriene activity, it helps to reduce inflammation, constriction of airways, and other symptoms associated with asthma and allergies. This medication is available in tablet or chewable tablet form, and it is typically taken orally once a day. Montelukast sodium is often prescribed as a long-term preventive therapy to control asthma symptoms and improve overall respiratory function.
According to DIResearch's in-depth investigation and research, the global Montelukast Sodium market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Montelukast Sodium include Morepen Laboratories, Mylan, TAPI, MSN Laboratories, Ultratech India, Aurobindo Pharma, Hetero Labs, Unimark Remedies, Jubilant Cadista, Aamorb Pharmaceuticals, Sudarshan Group, Ortin Laboratories, Adley Group, Vamsi Labs, Medopharm, Hengyuan Pharmaceutical, Arromax Pharmaceutical Technology, Lihe Wuhan New Chemical Materials, Shanghai Huachu Chemical etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Montelukast Sodium. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Montelukast Sodium market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Montelukast Sodium market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Montelukast Sodium industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Montelukast Sodium Include:
Morepen Laboratories
Mylan
TAPI
MSN Laboratories
Ultratech India
Aurobindo Pharma
Hetero Labs
Unimark Remedies
Jubilant Cadista
Aamorb Pharmaceuticals
Sudarshan Group
Ortin Laboratories
Adley Group
Vamsi Labs
Medopharm
Hengyuan Pharmaceutical
Arromax Pharmaceutical Technology
Lihe Wuhan New Chemical Materials
Shanghai Huachu Chemical
Montelukast Sodium Product Segment Include:
Montelukast Sodium Amorphous
Montelukast Sodium Crystalline
Montelukast Sodium Product Application Include:
Tablets
Chewable Tablet
Oral Solution
Chapter ScopeChapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Montelukast Sodium Industry PESTEL Analysis
Chapter 3: Global Montelukast Sodium Industry Porter’s Five Forces Analysis
Chapter 4: Global Montelukast Sodium Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis
Chapter 5: Global Montelukast Sodium Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Montelukast Sodium Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Montelukast Sodium Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Montelukast Sodium Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Montelukast Sodium Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Montelukast Sodium Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Montelukast Sodium Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Montelukast Sodium Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources